您的位置: 百康网 > 期刊 > 药学 > 《实验药学杂志》 > 2005年 > 2005年1月第1期 > 正文
Surviving low oxygen
 本页关键词:Surviving
2007-6-11 16:08:46

Neutrophils no longer survive hypoxia in the absence of HIF-1.

Hypoxia-inducible factor–1 (HIF-1) prolongs the life of oxygen-deprived neutrophils by inducing NF-B–driven survival signals, according to a study by Walmsley et al. on page 105. HIF-1, a transcription factor induced by low oxygen, is required for myeloid cell function but has never been linked to myeloid apoptosis. Walmsley et al. now show that cells lacking this protein are robbed of the ability to resist apoptosis in low-oxygen environments like those encountered in wounds and inflamed tissues.

Neutrophils must function in adverse environments where oxygen and nutrient supplies are low. To do this, they turn on HIF-1, which drives the synthesis of enzymes that make ATP anaerobically. In mice whose myeloid cells lack HIF-1, the cells quickly lose their ATP supplies and thus have no energy to migrate or function in response to inflammatory stimuli.

Neutrophils also delay apoptosis during hypoxia, and the authors now show HIF-1 is required for this delay. The accelerated death could be mimicked in HIF-1–positive cells by blocking NF-B, suggesting a key role for this transcription factor in prolonging survival. The authors speculate that the ability of HIF-1 to induce neutrophil survival might contribute to a delayed resolution of inflammation, making a bad situation even worse.

 



查询更多Surviving相关信息在本站>>

  

《实验药学杂志》2005年1月第201卷第1期 

评论】【打印】【 】【关闭
相关文章
Inhalational Anthrax after Bioterrorism Exposure: Spectrum of Imaging Findings in Two Surviving Patients1
Surviving rapamycin
Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus
Inhalational Anthrax after Bioterrorism Exposure: Spectrum of Imaging Findings in Two Surviving Patients
Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy
A new look for 2005
Heart-stopping antibodies
Trouble-making NKT cells
MBL is good for the heart
Discovering lymphocyte subsets